Table IV.
Timea | n | N | R | PH | R/PH | P-value |
---|---|---|---|---|---|---|
2 | 5 | 0.461±0.014 | 0.544±0.032 | 0.765±0.009 | 0.651±0.022 | 0.014 |
3 | 5 | 0.463±0.005 | 0.546±0.016 | 0.610±0.100 | 0.987±0.100 | <0.001 |
4 | 5 | 0.456±0.020 | 0.552±0.025 | 0.523±0.010 | 0.554±0.070 | 0.060 |
7 | 5 | 0.493±0.015 | 0.560±0.013 | 0.300±0.047 | 0.543±0.010 | 0.020 |
14 | 5 | 0.556±0.009 | 0.539±0.060 | 0.443±0.013 | 0.534±0.080 | 0.041 |
21 | 5 | 0.562±0.030 | 0.566±0.010 | 0.553±0.050 | 0.507±0.010 | 0.120 |
30 | 5 | 0.555±0.060 | 0.560±0.015 | 0.672±0.020 | 0.536±0.030 | 0.016 |
P-value | 0.54 | 0.39 | 0.002 | <0.001 |
Days post-PH. Data are presented as the mean ± standard deviation. N, normal control group; R, retrorsine-treated group; PH, partial hepatectomy; R/PH, retrorsine-treated plus PH group.